Daniel C. Javitt - 29 Nov 2022 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Reporting relationship: 10%+ Owner
Issuer ticker: NRXP
Reported as of: 29 Nov 2022
Net transaction value: -$33,352
SEC form: 4
Accepted by SEC: 01 Dec 2022, 18:29:11 UTC
Prior SEC filing: 18 Nov 2022
Source filing: View source filing
Reporting owner signature: Daniel Javitt

Key filing fact

Daniel C. Javitt filed Form 4 for NRX Pharmaceuticals, Inc. (NRXP) on 01 Dec 2022.

Key facts

This page summarizes Daniel C. Javitt's Form 4 filing for NRX Pharmaceuticals, Inc. (NRXP).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 01 Dec 2022, 18:29.

Change

Previous filing in this sequence was filed on 18 Nov 2022.
Current net transaction value: -$33,352.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NRXP transaction

common stock

Sale

Transaction value: $20,651
Shares: -13,730
Change %: -0.14%
Price: $1.50
Shares after: 9,643,234
Date: 29 Nov 2022
Ownership: by Glytech LLC
Footnotes: F1, F2

NRXP transaction

common stock

Sale

Transaction value: $12,700
Shares: -8,441
Change %: -0.09%
Price: $1.50
Shares after: 9,634,793
Date: 30 Nov 2022
Ownership: by Glytech LLC
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Sale was pursuant to the terms of a 10b5-1 trading plan established on June 13, 2022.

Footnote F2

Held by Glytech LLC of which the Reporting Person is the sole owner.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .